Cargando…

Potential for Drug Interactions and Polypharmacy From Treatment of COVID-19 in Long-Term Care

Detalles Bibliográficos
Autores principales:	Blaszczyk, Amie Taggart, Sandlin, Katherine, Mirza, Sumeen, Hernandez, Lilibeth, Bader, Hiba, Hall, Ronald G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AMDA - The Society for Post-Acute and Long-Term Care Medicine. 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983604/ https://www.ncbi.nlm.nih.gov/pubmed/35504327 http://dx.doi.org/10.1016/j.jamda.2022.03.016

Ejemplares similares

Observations of Polypharmacy and Interactions on Varying COVID-19 Medication Regimens in Nursing Home Residents
por: Sandlin, Katherine, et al.
Publicado: (2021)

Adverse drug reactions in the era of multi-morbidity and polypharmacy
por: Birriel, T. Javier, et al.
Publicado: (2015)

Polypharmacy and potential drug–drug interactions in emergency department patients in the Caribbean
por: Dookeeram, Darren, et al.
Publicado: (2017)

Polypharmacy and potential drug–drug interactions among Greenland’s care home residents
por: Albertsen, Nadja, et al.
Publicado: (2022)

Evaluation of potential drug-drug interactions and polypharmacy in hospitalized COVID-19 patients
por: Kilit, Türkan Paşalı, et al.
Publicado: (2022)

The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010
por: Guthrie, Bruce, et al.
Publicado: (2015)

Drug-drug interactions in polypharmacy patients: The impact of renal impairment
por: Papotti, Bianca, et al.
Publicado: (2021)

Targeting continuity of care and polypharmacy to reduce drug–drug interaction
por: Weng, Yi-An, et al.
Publicado: (2020)

Prevalence and Severity of Potential Drug–Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy
por: Bachmann, Paula, et al.
Publicado: (2022)

Polypharmacy, Potentially Inappropriate Medications, and Drug-to-Drug Interactions in Patients with Chronic Myeloproliferative Neoplasms
por: Krečak, Ivan, et al.
Publicado: (2023)

Polypharmacy, potentially inappropriate medications, and drug-drug interactions in older COVID-19 inpatients
por: Chen, Zhaoyan, et al.
Publicado: (2023)

Polypharmacy: The past, present and the future
por: Kaur, Ginpreet
Publicado: (2013)

Polypharmacy and potential drug–drug interactions for people with HIV in the UK from the Climate‐HIV database
por: Okoli, C, et al.
Publicado: (2020)

Prevalence of polypharmacy and risk of potential drug-drug interactions among hospitalized patients with emphasis on the pharmacokinetics
por: Georgiev, Kaloyan D., et al.
Publicado: (2022)

Polypharmacy, Potentially Inappropriate Medications, and Drug-Drug Interactions in Vulnerable Older Adults With Advanced Cancer Initiating Cancer Treatment
por: Ramsdale, Erika, et al.
Publicado: (2022)

Prescription Advice Based on Data of Drug-Drug-Gene Interaction of Patients with Polypharmacy
por: Salamone, Sandro, et al.
Publicado: (2022)

Polypharmacy, Drug–Drug Interactions, and Inappropriate Drugs: New Challenges in the Aging Population With HIV
por: Courlet, Perrine, et al.
Publicado: (2019)

Prevalence and Variability in Medications Contributing to Polypharmacy in Long-Term Care Facilities
por: Jokanovic, Natali, et al.
Publicado: (2017)

POLYPHARMACY VERSUS DRUG COMBINATIONS
por: Agarwal, A.K.
Publicado: (1991)

The prevalence and severity of potential drug-drug interactions among adult polypharmacy patients at outpatient clinics in Jordan
por: Nusair, Mohammad B., et al.
Publicado: (2020)

Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States
por: Sheikh-Taha, Marwan, et al.
Publicado: (2021)

Polypharmacy and Potential Drug–Drug Interactions in Home-Dwelling Older People – A Cross-Sectional Study
por: Hermann, Monica, et al.
Publicado: (2021)

Risk of Polypharmacy and Its Outcome in Terms of Drug Interaction in an Elderly Population: A Retrospective Cross-Sectional Study
por: Alhumaidi, Reham M., et al.
Publicado: (2023)

Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review
por: Rodrigues, Maria Cristina Soares, et al.
Publicado: (2016)

The risk of polypharmacy, comorbidities and drug–drug interactions in women of childbearing age with multiple sclerosis
por: Frahm, Niklas, et al.
Publicado: (2020)

Gender differences, polypharmacy, and potential pharmacological interactions in the elderly
por: Venturini, Carina Duarte, et al.
Publicado: (2011)

A nurse practitioner led protocol to address polypharmacy in long-term care
por: Bergman-Evans, Brenda
Publicado: (2020)

Deprescribing and Polypharmacy for Medicare Beneficiaries Under Guardianship in Long-Term Care Facilities
por: Swenson, Tami
Publicado: (2020)

A review of citalopram dose restrictions in the treatment of neuropsychiatric disorders in older adults
por: McCarrell, Jamie L., et al.
Publicado: (2019)

What Should Clinicians Do for Older Adults with Polypharmacy and Depression? [Letter]
por: Zhu, Ling-Ling, et al.
Publicado: (2022)

Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region
por: Burato, Sofia, et al.
Publicado: (2021)

Predictors of long-term (≥ 6 months) antipsychotic polypharmacy prescribing in secondary mental healthcare
por: Kadra, Giouliana, et al.
Publicado: (2016)

Long‐term antipsychotic polypharmacy prescribing in secondary mental health care and the risk of mortality
por: Kadra, G., et al.
Publicado: (2018)

Long-term exposure to polypharmacy impairs cognitive functions in young adult female mice
por: Francesca, Eroli, et al.
Publicado: (2021)

Nationwide Long-Term Evaluation of Polypharmacy Reduction Policies Focusing on Older Adults in Japan
por: Ishida, Takehiro, et al.
Publicado: (2022)

Multimorbidity and Polypharmacy in Psychosis: Identifying Potentially Significant Drug Interactions in an Old Age Inpatient Psychiatry Setting
por: Tewari, Abhinav, et al.
Publicado: (2023)

Prevalence of Polypharmacy and Drug Interaction Among Hospitalized Patients: Opportunities and Responsabilities in Pharmaceutical Care
por: Trumic, Edisa, et al.
Publicado: (2012)

A study of harmful drug–drug interactions due to polypharmacy in hospitalized patients in Goa Medical College
por: Khandeparkar, Akshay, et al.
Publicado: (2017)

Using INTERCheck(®) to Evaluate the Incidence of Adverse Events and Drug–Drug Interactions in Out- and Inpatients Exposed to Polypharmacy
por: Martocchia, Antonio, et al.
Publicado: (2020)

Polypharmacy in chronic liver disease patients: Implications for disease severity, drug-drug interaction, and quality of life
por: Farooq, Juveriya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1t4frikkp5d2r4e99sggbq253d